ZACCARDELLI DAVID (President & CEO) sold 11.3% of their position (10.45K shares) of DOVA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $166.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/3/2019ACC: 0001209191-19-041095
Officer· President & CEO
Since Dec 2018
-10.45K
Net shares
Net seller
$166.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.90K
Price / share
$15.73
Trade value
$92.79K
% of position
6.4%
7/2/2019
92.37K→86.47K
Common Stock
Direct
Shares
−4.55K
Price / share
$16.22
Trade value
$73.82K
% of position
5.3%
7/2/2019
86.47K→81.92K
Total
Net shares
−10.45K
Net value
-$166.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2019 | S · Sale | −5.90K | $15.73 | $92.79K | 6.4% | 92.37K | 86.47K |
| Common Stock Direct | 7/2/2019 | S · Sale | −4.55K | $16.22 | $73.82K | 5.3% | 86.47K | 81.92K |
| Total | −10.45K | -$166.61K | ||||||
Derivative Transactions0
No derivative transactions reported